ACS: 180 AND ADVIA CENTAUR ANTI-THYROGLOBULIN IMMUNOASSAYS— 510(k) K012777

Substantially Equivalent

Bayer Corp.

FDA 510(k) clearance K012777 for ACS: 180 AND ADVIA CENTAUR ANTI-THYROGLOBULIN IMMUNOASSAYS, Substantially Equivalent on 2001-10-22. Applicant: Bayer Corp..

Clearance details

Applicant: Bayer Corp.
Product code: Code JZO
Advisory panel: Immunology
Date received: 2001-08-20
Decision date: 2001-10-22
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Tarrytown, NY, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.